Student Name
University of Phoenix
NSG/486 Public Health: Health Promotion and Disease Prevention
Prof. Name:
Date
Substance abuse remains one of the most significant public health challenges in the United States. Healthy People 2020 identified substance abuse as a Leading Health Indicator (LHI) because reducing alcohol and drug use—especially among adolescents—improves individual health, strengthens communities, and lowers healthcare, criminal justice, and economic costs. Alaska addresses this issue through statewide prevention initiatives led by the Office of Substance Misuse and Addiction Prevention (OSMAP).
Leading Health Indicators (LHIs) are priority public health objectives established by Healthy People 2020 to help federal, state, and local organizations focus on the nation’s most pressing health concerns. These indicators provide measurable goals that guide policy development, prevention strategies, and health improvement efforts across the United States.
Substance abuse is one of the key LHIs because it affects physical health, mental health, family stability, education, employment, and public safety.
Substance abuse involves the harmful use of alcohol, illicit drugs, prescription medications, or multiple substances. It contributes to numerous health and social problems, including:
Family disruption
Poor academic performance
Unemployment
Financial hardship
Domestic violence
Child neglect and abuse
Increased crime
Mental health disorders
Chronic disease
Premature death
Substance use disorders also create a significant financial burden. According to Healthy People 2020, substance abuse costs the United States more than $600 billion annually through healthcare expenses, lost workplace productivity, and criminal justice costs.
Healthy People 2020 established measurable objectives to reduce alcohol and illicit drug use among adolescents aged 12–17 years.
14.2%Â of adolescents reported alcohol or illicit drug use within the previous 30 days (2015).
Reduce adolescent substance use to 12.8%, representing a 10% improvement from the baseline.
These objectives encourage evidence-based prevention programs and community interventions that reduce substance use before addiction develops.
Alaska demonstrates both strengths and ongoing challenges when compared with national averages.
| Population | Alaska | United States |
|---|---|---|
| Total | 13% | 16% |
| Male | 14% | 18% |
| Female | 12% | 13% |
Alaska reports lower rates of early alcohol initiation than the national average.
| Population | Alaska | United States |
|---|---|---|
| Total | 23% | 30% |
| Male | 18% | 28% |
| Female | 28% | 32% |
Recent alcohol consumption among adolescents is also lower in Alaska overall.
| Population | Alaska | United States |
|---|---|---|
| Total | 42% | 36% |
| Male | 40% | 35% |
| Female | 44% | 36% |
Marijuana use among Alaska adolescents exceeds the national average, highlighting an area requiring continued prevention and education.
Alaska:Â 4%
United States:Â 4%
| Population | Alaska | United States |
|---|---|---|
| Total | 4% | 5% |
| Male | 4% | 6% |
| Female | 4% | 3% |
The Office of Substance Misuse and Addiction Prevention (OSMAP) was established in July 2017 to reduce substance misuse, prevent addiction, and improve public health throughout Alaska.
Prevent substance misuse before it begins.
Reduce opioid- and marijuana-related harm.
Increase access to prevention and treatment services.
Support community-based prevention initiatives.
Improve health education and public awareness.
Opioid misuse prevention
Marijuana education
Marijuana treatment services
Fetal Alcohol Spectrum Disorders (FASD)
Workforce development
Community prevention partnerships
Addiction and the Workplace
Project Hope
Alaska Statewide Opioid Action Plan
OSMAP focuses on prevention, treatment access, and long-term community resilience.
Its major outcomes include:
Promoting health throughout every stage of life.
Preventing substance use before addiction develops.
Reducing overdose risk and substance-related harm.
Expanding treatment through workforce development.
Building stronger and more resilient communities.
Supporting long-term recovery for Alaskans.
Substance abuse imposes a substantial economic burden on Alaska.
$3.45 billion in total annual costs
$1.1 billion in lost productivity
$659 million in criminal justice and court expenses
Funding supports multiple prevention and treatment initiatives, including:
$1,214,300Â for staffing, infrastructure, and community support
$1,027,000Â for Fetal Alcohol Spectrum Disorder programs and marijuana education
$3,445,900Â for:
Overdose surveillance
Harm reduction initiatives
Community health literacy
Prescription Drug Monitoring Program enhancements
Prevention and recovery programs
These investments strengthen Alaska’s ability to prevent substance misuse while improving treatment access and public health outcomes.
Substance abuse is a national Leading Health Indicator because of its widespread health, social, and economic impact.
Healthy People 2020 aimed to reduce adolescent alcohol and illicit drug use from 14.2% to 12.8%.
Alaska performs better than the national average for adolescent alcohol use but experiences higher rates of marijuana use.
OSMAP provides statewide leadership through prevention, education, treatment support, and community partnerships.
Continued investment in prevention programs can reduce healthcare costs, improve quality of life, and strengthen communities.
A Leading Health Indicator is a priority health objective identified by Healthy People 2020 to measure progress toward improving public health in the United States.
Substance abuse contributes to chronic disease, mental illness, family disruption, crime, lost productivity, and increased healthcare costs, making it a major public health concern.
Healthy People 2020 sought to reduce the percentage of adolescents aged 12–17 who used alcohol or illicit drugs within the previous 30 days from 14.2% to 12.8%.
The Office of Substance Misuse and Addiction Prevention (OSMAP) is Alaska’s statewide program dedicated to preventing substance misuse, expanding education, supporting treatment, and improving community health.
Compared with national averages, Alaska reports lower adolescent alcohol use but higher marijuana use, while opioid and cocaine use remain similar to U.S. averages.
Prevention programs reduce addiction risk, lower healthcare and criminal justice costs, improve educational outcomes, and create healthier, safer communities.
Healthy People 2020 identifies substance abuse as a Leading Health Indicator because reducing alcohol and drug use improves public health, lowers healthcare costs, and strengthens communities. Alaska addresses adolescent substance misuse through the Office of Substance Misuse and Addiction Prevention (OSMAP), which funds prevention, education, treatment support, opioid response initiatives, and community-based programs aimed at reducing addiction and promoting long-term recovery.
Research indicates that early prevention, community education, and access to treatment are among the most effective strategies for reducing adolescent substance use. Alaska’s investment in surveillance, prevention initiatives, workforce development, and recovery services supports evidence-based public health approaches that align with national Healthy People objectives.
Alaska Department of Health and Social Services. (2019). Office of Substance Misuse and Addiction Prevention. https://health.alaska.gov/osmap/
Office of Adolescent Health. (2019). Alaska adolescent substance abuse facts. U.S. Department of Health and Human Services. https://www.hhs.gov/ash/oah/
Office of Disease Prevention and Health Promotion. (2020). Leading Health Indicators. Healthy People 2020. https://www.healthypeople.gov/2020/topics-objectives/topic/leading-health-indicators
Office of Disease Prevention and Health Promotion. (2020). Substance abuse. Healthy People 2020. https://www.healthypeople.gov/2020/topics-objectives/topic/substance-abuse
Post Categories
Tags